128 related articles for article (PubMed ID: 28915684)
1. Lack of association between NAT2 polymorphism and prostate cancer risk: a meta-analysis and trial sequential analysis.
Wang F; Qin Z; Si S; Tang J; Xu L; Xu H; Li R; Han P; Yang H
Oncotarget; 2017 Aug; 8(34):57440-57450. PubMed ID: 28915684
[TBL] [Abstract][Full Text] [Related]
2. Association between TNF-ɑ-308G/A polymorphism and esophageal cancer risk: An updated meta-analysis and trial sequential analysis.
Yang F; Wei K; Qin Z; Shao C; Shu Y; Shen H
J Cancer; 2019; 10(5):1086-1096. PubMed ID: 30854115
[No Abstract] [Full Text] [Related]
3. Association between insulin-like growth factor-binding protein-3 polymorphism-202 A/C and the risk of prostate cancer: a meta-analysis.
Qin Z; Li X; Tang J; Jiang X; Yu Y; Wang C; Xu W; Hua Y; Yu B; Zhang W
Onco Targets Ther; 2016; 9():5451-9. PubMed ID: 27660462
[TBL] [Abstract][Full Text] [Related]
4. Association between cyclooxygenase-2 (COX-2) 8473 T > C polymorphism and cancer risk: a meta-analysis and trial sequential analysis.
Li Q; Ma C; Zhang Z; Chen S; Zhi W; Zhang L; Zhang G; Shi L; Cao F; Ma T
BMC Cancer; 2018 Aug; 18(1):847. PubMed ID: 30143023
[TBL] [Abstract][Full Text] [Related]
5. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
[TBL] [Abstract][Full Text] [Related]
6. Association between manganese superoxide dismutase (MnSOD) polymorphism and prostate cancer susceptibility: a meta-analysis.
Li X; Shen M; Cai H; Liu K; Liu Y; Huang Z; Liang C; Deng X; Ye J; Zou Q; Li J
Int J Biol Markers; 2016 Dec; 31(4):e422-e430. PubMed ID: 27055786
[TBL] [Abstract][Full Text] [Related]
7. Association between PSCA gene polymorphisms and the risk of cancer: an updated meta-analysis and trial sequential analysis.
Qin Z; Tang J; Li X; Yu Y; Zhang C; Han P; Li R; Jiang X; Yang C; Wang W; Tang M; Zhang W
Oncotarget; 2017 Aug; 8(31):51766-51778. PubMed ID: 28881685
[TBL] [Abstract][Full Text] [Related]
8. NAT2 polymorphism and lung cancer risk: a meta-analysis.
Cui D; Wang Z; Zhao E; Ma J; Lu W
Lung Cancer; 2011 Aug; 73(2):153-7. PubMed ID: 21292342
[TBL] [Abstract][Full Text] [Related]
9. Association between 8q24 rs6983267 polymorphism and cancer susceptibility: a meta-analysis involving 170,737 subjects.
Zhu M; Wen X; Liu X; Wang Y; Liang C; Tu J
Oncotarget; 2017 Aug; 8(34):57421-57439. PubMed ID: 28915683
[TBL] [Abstract][Full Text] [Related]
10. Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studies.
Jiang X; Zhang M; Bai XY; Li S; Wu H
Onco Targets Ther; 2016; 9():4491-503. PubMed ID: 27524905
[TBL] [Abstract][Full Text] [Related]
11. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
12. Association between 8q24 Gene Polymorphisms and the Risk of Prostate Cancer: A Systematic Review and Meta-Analysis.
Li R; Qin Z; Tang J; Han P; Xing Q; Wang F; Si S; Wu X; Tang M; Wang W; Zhang W
J Cancer; 2017; 8(16):3198-3211. PubMed ID: 29158792
[TBL] [Abstract][Full Text] [Related]
13. The association between rs9642880 gene polymorphism and bladder cancer risk: a meta-analysis.
Tang J; Li X; Jiang X; Xu W; Xu Z; Wang W; Liu B; Lv Q; Zhang W
Int J Clin Exp Med; 2015; 8(11):20236-44. PubMed ID: 26884936
[TBL] [Abstract][Full Text] [Related]
14. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.
Yin YW; Li JC; Zhang M; Wang JZ; Li BH; Liu Y; Liao SQ; Zhang MJ; Gao CY; Zhang LL
Gene; 2013 Oct; 529(1):94-103. PubMed ID: 23954871
[TBL] [Abstract][Full Text] [Related]
15. Association of N-acetyltransferase 1 polymorphism and bladder cancer risk: an updated meta-analysis and trial sequential analysis.
Xu Z; Li X; Qin Z; Xue J; Wang J; Liu Z; Cai H; Yu B; Xu T; Zou Q
Int J Biol Markers; 2017 Jul; 32(3):e297-e304. PubMed ID: 28604993
[TBL] [Abstract][Full Text] [Related]
16. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression.
Li YL; Tian Z; Zhao L; Zhang CL
Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191
[TBL] [Abstract][Full Text] [Related]
17. Association between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjects.
Ao X; Liu Y; Bai XY; Qu X; Xu Z; Hu G; Chen M; Wu H
Onco Targets Ther; 2015; 8():1671-80. PubMed ID: 26185455
[TBL] [Abstract][Full Text] [Related]
18. N-acetyltransferase 2 phenotype and risk of esophageal cancer: a meta analysis.
Ma RL; Min L; Chen D; Tao WP; Ge W; Wu YG
Cancer Biomark; 2013 Jan; 13(6):447-55. PubMed ID: 24595082
[TBL] [Abstract][Full Text] [Related]
19. NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.
Wang PY; Xie SY; Hao Q; Zhang C; Jiang BF
Int J Tuberc Lung Dis; 2012 May; 16(5):589-95. PubMed ID: 22409928
[TBL] [Abstract][Full Text] [Related]
20. Association of NAT2 phenotype with risk of head and neck carcinoma: A meta-analysis.
Zheng Y; Li Y; Teng Y; Zhang Z; Cao X
Oncol Lett; 2012 Feb; 3(2):429-434. PubMed ID: 22740926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
